'indian ip and liabilities law barrier to pharma r&d investment'
.
.
this week's flyers
.
of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met.
. in washington before heading to baltimore for saturday's broadcast of
.
former novartis exec to lead cambridge diabetes startup semma
.